Cargando…
Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer’s-like memory deficits in the Ts65Dn mouse model of Down syndrome
Down syndrome (DS), caused by trisomy 21, is the most common genetic cause of intellectual disability and is associated with a greatly increased risk of early-onset Alzheimer’s disease (AD). The Ts65Dn mouse model of DS exhibits several key features of the disease including developmental delay and A...
Autores principales: | Kazim, Syed Faraz, Blanchard, Julie, Bianchi, Riccardo, Iqbal, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377379/ https://www.ncbi.nlm.nih.gov/pubmed/28368015 http://dx.doi.org/10.1038/srep45561 |
Ejemplares similares
-
Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome
por: Fulton, Sasha L., et al.
Publicado: (2022) -
Pathological trajectory in the Ts65Dn model of Down syndrome
por: Tallino, Savannah, et al.
Publicado: (2023) -
Glutamatergic synaptic deficits in the prefrontal cortex of the Ts65Dn mouse model for Down syndrome
por: Thomazeau, Aurore, et al.
Publicado: (2023) -
Protein Dynamics Associated with Failed and Rescued Learning in the Ts65Dn Mouse Model of Down Syndrome
por: Ahmed, Md. Mahiuddin, et al.
Publicado: (2015) -
Cholinergic Senescence in the Ts65Dn Mouse Model for Down Syndrome
por: Kirstein, Martina, et al.
Publicado: (2022)